Glutathione is a tripeptide antioxidant central to cellular protection that people run mainly for skin health, liver support, and detoxification, with liver and antioxidant reports tracking at 100% positive and neurological benefits noted in a smaller cohort. Because community dosing is inconsistent, the only captured clinician guidance suggests 200 mg subcutaneously twice daily on a continuous, non-cycled schedule. The tradeoff is that the off-label evidence base is thinner than the discourse suggests; most exploratory indications rest on trials that have not posted results.

Research Evidence
Evidence shape
Evidence for glutathione is moderate, with the strongest trial reaching Phase 3 and the most data concentrated in Parkinson’s disease, cystic fibrosis, and autism spectrum disorder. Still, only one blinded study has posted results across 13 distinct sponsors, and while 26 indications have been mapped, 23 are thin or exploratory and 21 rest on a single trial. The majority of completed studies have no posted outcomes, leaving the long tail studied but not at scale.
Anecdotal efficacy
Side effects
Clinical research side effects
Anecdotal side effects
Price
price offers can be sorted by column
Dosing & Protocol
How Glutathione is dosed across research, clinician, and community sources — each evidence tier kept separate so the dose range, frequency, timing, and cycling stay visible without flattening different levels of evidence.
14 completed trials identified; trial dosing not reliably extracted from registry data.
Clinician protocols dose 200 mg BID oral (2 sources).
No structured protocol details captured for this tier yet.
Community reports indicate Glutathione use across several areas: 4 reports for antioxidant/detox (50% positive), 4 reports for liver support (100% positive), 7 reports for skin health/appearance (85.7% positive), and 5 reports for neurological support (100% positive). Specific dosing details are not consistently available from these anecdotal reports.
Peptide Deep Dive
Peptide Deep Dive is not projected for this peptide yet.
Regulatory safety notes
Peptide feedback
0 forum repliesLive community discussion for Glutathione, shown here in the site layout and continued on the TVR forum.
No peptide feedback yet
Start the peptide feedback thread on the TVR forum.